Management of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme.

Simple item page
dc.contributor.authorPrabhakaran, Den_US
dc.contributor.authorJeemon, Pen_US
dc.contributor.authorMohanan, P Pen_US
dc.contributor.authorGovindan, Uen_US
dc.contributor.authorGeevar, Zen_US
dc.contributor.authorChaturvedi, Ven_US
dc.contributor.authorReddy, K Sen_US
dc.date.accessioned2008-05-14en_US
dc.date.accessioned2009-06-03T07:09:44Z
dc.date.available2008-05-14en_US
dc.date.available2009-06-03T07:09:44Z
dc.date.issued2008-05-14en_US
dc.description.abstractBACKGROUND: Evidence-based therapies that have been shown to improve outcomes in acute coronary syndromes (ACS) are often underused in clinically eligible patients. We evaluated the impact, efficacy and acceptability of a quality improvement programme to manage ACS. METHODS: A well-defined geographical area was identified and a situational analysis done. All physicians in the area, who were actively involved in the detection and management of ACS, were invited to participate in the quality improvement programme. The programme involved the use of a service delivery package which consisted of standard admission orders and patient-directed discharge instructions. Concurrently, health education in the community to promote self-detection, self-administration of aspirin and self-referral were carried out. All participating physicians were asked to register consecutive cases of ACS (20 each) presenting to their clinics before and after the intervention programme. The pre- and post-intervention data were compared. RESULTS: The use of aspirin at discharge increased from 89.7% to 96.8% (p < 0.05) and that of heparin from 57.6% to 66.3% (p < 0.05). The use of beta-blockers increased from 48.6% to 63.4% (p < 0.05) and that of lipid-lowering therapy from 74.1% to 96.3% (p < 0.05). There was a significant reduction in the use of calcium channel blockers from 21.6% to 8.1% (p < 0.05). The time to thrombolysis decreased significantly (median difference of 54 minutes, p < 0.05) after the intervention programme. CONCLUSION: Structured quality improvement programmes aimed at both patients and providers can be successful in secondary care settings of developing countries.en_US
dc.description.affiliationCentre for Chronic Disease Control, New Delhi 110016, India.en_US
dc.identifier.citationPrabhakaran D, Jeemon P, Mohanan PP, Govindan U, Geevar Z, Chaturvedi V, Reddy KS. Management of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme. National Medical Journal of India. 2008 May-Jun; 21(3): 107-11en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/119529
dc.language.isoengen_US
dc.source.urihttps://www.nmji.inen_US
dc.subject.meshAcute Coronary Syndrome --drug therapyen_US
dc.subject.meshAdrenergic beta-Antagonists --administration & dosageen_US
dc.subject.meshAgeden_US
dc.subject.meshAntilipemic Agents --administration & dosageen_US
dc.subject.meshAspirin --administration & dosageen_US
dc.subject.meshCalcium Channel Blockers --administration & dosageen_US
dc.subject.meshEvidence-Based Medicineen_US
dc.subject.meshFemaleen_US
dc.subject.meshHealth Educationen_US
dc.subject.meshHeparin --administration & dosageen_US
dc.subject.meshHumansen_US
dc.subject.meshIndiaen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshQuality of Health Careen_US
dc.subject.meshThrombolytic Therapyen_US
dc.titleManagement of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme.en_US
dc.typeJournal Articleen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
National Medical Journal of India